GXMC
HRTX icon

Global X Management Company’s Heron Therapeutics HRTX Stock Holding History

Global X Management Company’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.08M Sell
27,805
-3,501
-11% -$111K 0.02% 441
2018
Q1 		$864K Buy
+31,306
New +$710K 0.02% 458
2015
Q4 		– Sell
-389
Closed -$9K – 916
2015
Q3 		$9K Buy
+389
New +$13K ﹤0.01% 642

Other funds holding HRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Global X Management Company's HRTX Position: Q2 2018 in Review

Global X Management Company reduced its Heron Therapeutics (HRTX) stake by 11% in Q2 2018, selling an estimated $111K and leaving 27,805 shares worth $1.08M. The position accounts for 0.02% of the portfolio, ranked #441.

Global X Management Company first reported a position in HRTX in Q3 2015 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold HRTX as of Q2 2018.

  • Global X Management Company held 27,805 shares of Heron Therapeutics worth $1.08M as of Q2 2018.
  • Global X Management Company sold 3,501 Heron Therapeutics shares in Q2 2018, an estimated $111K.
  • Heron Therapeutics made up 0.02% of Global X Management Company's portfolio in Q2 2018, its #441 holding.
  • Global X Management Company first reported a position in Heron Therapeutics in Q3 2015 and has held it in 3 quarters since.
  • 196 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.